Léim go dtí an t-ábhar
CureSight Gléas Cóireála Súl Leisciúil le Kobi Kor

Is buaiteoir an-mheasúil den ghradam fíor-ardghradamach 2022 Duais Iarainn A' Design Award sa Chatagóir Comórtais Dearadh Táirge Leighis é an dearadh CureSight Gléas Cóireála Súl Leisciúil le Kobi Kor.


IarannTáirge Leighis· 2022

CureSight Gléas Cóireála Súl Leisciúil

le Kobi Kor

Cliant: Novasight

Buaiteoir an ghradaim Duais Iarainn A' Design Award sa Chatagóir Táirge Leighis

22,237

Buaiteoir Gradaim Fíoraithe

Fíoraigh Stádas Gradaim do #133911

Dathanna

An Dearadh

Maidir le CureSight Gléas Cóireála Súl Leisciúil

Dhírigh próiseas deartha CureSight ar tháirge agus ar réiteach cóireála a chruthú a dhéanfaidh tionchar sóisialta dearfach agus a chabhróidh le hothair, ar leanaí iad an chuid is mó díobh, chun an míchompord agus an náire a bhaineann leis an gcóireáil thraidisiúnta leis an paiste súl a sheachaint. Leagann an dearadh béim freisin go bhfuil cuma agus mothú an táirge riachtanach chun na páistí a spreagadh agus a chumasú. Tháinig an inspioráid don dearadh stílithe ó na giuirléidí teicneolaíochta is breá le páistí a úsáid agus a imirt leis. Soláthraíonn an dearadh cruth cuma slick agus nua-aimseartha do tháirge feiste leighis.

An Aitheantas

Maidir leis an Duais Iarainn A' Design Award

Bhuaigh an dearadh CureSight Gléas Cóireála Súl Leisciúil Duais Iarainn A' Design Award, aitheantas gradamach a bhronntar ar dhea-dhearaí a chomhlíonann na riachtanais ghairmiúla agus thionsclaíocha a bhíonn á n-éileamh ó chruthuithe a ndearnadh go maith iad. Léiríonn buaiteoirí Iarainn scil mhór, speisialtóireacht ard, tuiscint saineolaí agus cumas cruthaitheach a gcruthaitheoirí. Táthar ag súil go mbeidh an dearadh CureSight Gléas Cóireála Súl Leisciúil ina chruthú a bhfuil an-mheas air, a n-ardaítear agus a ghráitear atá praiticiúil agus nuálach. Comhtháthaíonn an dearadh seo a bhuaigh Duais Iarainn A' Design Award na cleachtais is fearr sa tionscal agus tá saintréithe teicniúla inniúla aige nasctha le heolas agus le tallann. Tá meas ar an dearadh CureSight Gléas Cóireála Súl Leisciúil as a dhúthracht agus dearadh é chun feabhsuithe cáilíochta beatha a sholáthar a chabhraíonn leis an domhan a dhéanamh ina áit níos fearr.

Taobh Thiar den Dearadh

Pacáiste Preasa

Creidiúintí, baill foirne agus sonraí teicniúla curtha ar fáil ag an dearthóir.

Airíonna Uathúla
The curesight is a powerful solution with great potential to totally change the treatment of lazy eye condition, with the important advantage of treating the lazy eye from the comfort of home and by watching any tv or streaming video content.
This healthcare solution for lazy eye condition integrates high-end technologies for eye-tracking and ai software tools for smart analyzing of the lazy eye condition and providing personal custom treatment. The gold standard care for lazy eye is placing a patch over the strong eye, an old-fashioned solution that suffers from very low compliance.
Toisí & Pacáistiú
product net dimensions
Height 230mm
Width 390mm
Depth 60mm
Clibeanna
amlyopia, lazy eye, medical device, product design, social impact, degital healthcare
Teicneolaíocht Táirgthe
The design activity started with a brainstorming meeting to learn more about the problem from the clinical and user needs aspects, and to outline the main big limitations of today's treatment methods.
We also discussed the ergonomics and usability needs to be able to provide the best treatment.
during the design process, we tested several design concepts both aesthetically and with physical mockups,
Production technologies include aluminum CNC machining and anodize plating, for the front bezel and plastic injection for the back cover and small covers.
Dúshlán Deartha
The creative challenge was to dress the unique technology components with style and to provide a good user experience to the users, the specific usability needs to enable good treatment for various populations and make it an appealing and empowering treatment device, and lead to important social impact
Taighde
Following an intense effort over the last 18 months, the company officially announced that the company successfully met the primary endpoint of the CureSight randomized, controlled pivotal trial of amblyopia treatment against the gold standard patching.
This is the first-ever pivotal study in which a digital device was shown to be non-inferior to eye patching for amblyopia treatment in children.
The study also exhibited 93% adherence to the curesight treatment, as well as a 93% likelihood of the parents choosing curesight over patching.
Inspioráid
The inspiration for the curesight product started from a personal experience when one of my kids needed to treat the lazy eye condition with the eye patch solution, I learned from this experience about the discomfort of wearing the eye patch for a few hours every day and especially how embarrassing it is from the social point of view.
The inspiration for the styling design came from the tech gadgets that kids love to use and play with, to provide a slick and modern design to a medical device product type, the front aluminum bezel, and the back swallowtail gives the product a clean gadget look.
Fad an Tionscadail
The project started in 2019 in Tel Aviv, and finished in late 2021, the project was exhibited at the CES in January 2020 in Las Vegas
Sreabhadh Oibríochta
The patient, most likely kids will have the fun be treated by the Curesight while watching any video content they love to watch without any degradation in quality and from the comfort of home.
Baill Foirne
Kobi Kor
Tal Samet
Creidiúintí Íomhá
All images
Photograph and Illustrations: Novasight and Kobi Kor

Urraithe

Déan Iniúchadh Lasmuigh de Designers.org

Aimsigh táirgí, seirbhísí agus deiseanna ónár gcomhpháirtithe fógraíochta.

Tuillíonn Dea-Dhearadh Aitheantas Iontach

Is gradam idirnáisiúnta moltóirí don dea-dhearadh é Gradam Deartha A'. Glac páirt i nGradam Deartha A' chun deis a fháil aitheantas fiúntach a bhaint amach, cáil, gradam agus poiblíocht a ghnóthú do do chuid oibre. Ainmnigh do shaothar do Ghradam Deartha A' agus bí san iomaíocht do Dhuais luachmhar Deartha A'.

Ainmnigh